Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 3Adenoma 2Venous Thromboembolism 1Urinary Bladder Neoplasms 1Thrombocytopenia 1Soft Tissue Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Node Positive HER2 Negative Breast Cancer 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Myocardial Infarction 1Multiple Myeloma 1Hereditary Sensory and Autonomic Neuropathies 1Hematuria 1Hematologic Diseases 1Glioblastoma 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Adenomatous Polyps 1Adenocarcinoma of Lung 1Acute Coronary Syndrome 1

Interventions

Fulvestrant 3Alpelisib 3duvelisib 2Cetuximab 2volagidemab 1talazoparib 1ruxolitinib 1parsaclisib 1olaparib 1obinutuzumab 1lorlatinib 1encorafenib 1dapagliflozin 1cobimetinib 1chiauranib 1binimetinib 1avelumab 1Vemurafenib 1SF 1126 1Rituximab 1NVP-BKM120 1Drug Therapy 1CYH33 1Aspirin 12-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Hereditary Sensory and Autonomic Neuropathies × Aspirin × Clear all
NCT02467582 2025-05-16

Adjuvant Aspirin Treatment for Colon Cancer Patients

Swiss Cancer Institute

Phase 3 Terminated
1,040 enrolled 11 charts
Gastrointestinal

Colonic Neoplasms, Hereditary Sensory and Autonomic Neuropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡